Overview

68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal Tumor

Status:
Recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the diagnostic performance and evaluation efficacy of 68Ga-NOTA-RM26 in Gastrointestinal stromal tumor(GIST)patients. A single dose of 55.5 to 148 MBq(1.5-4 mCi) of 68Ga-NOTA-RM26 will be injected intravenously. Patients underwent whole-body PET/CT scans at 30-90 minutes after intravenous injection.
Phase:
Early Phase 1
Details
Lead Sponsor:
Peking Union Medical College Hospital
Treatments:
68Ga-NOTA-RM26